All In Biotech

Drug Trial Radar · NCT07781644

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

A Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of RO7568282 in Participants With Early-stage Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 474 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

474

Planned (sponsor's estimate)

Start

Nov 11, 2026

Primary completion

Dec 15, 2028

Study completion Apr 15, 2032

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Aug 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of RO7568282 compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

Conditions

  • Parkinson's Disease

Interventions

  • RO7568282Drug

    RO7568282 will be administered as per the schedule specified in the protocol.

  • PlaceboDrug

    Placebo will be administered as per the schedule specified in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to a Confirmed Motor Progression Event From the Randomization Date, as Measured by the MDS-UPDRS Part III ScoreTime frame: Up to at least Week 104

Locations

6 sites in 5 countries. Site status is shown where the registry gives one.

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida · Recruiting

  • Huashan Hospital, Fudan University

    Shanghai, China · Recruiting

  • Cork University Hospital

    Cork, Ireland · Recruiting

  • Centrum Medyczne NeuroProtect

    Warsaw, Poland · Recruiting

  • Ninewells Hospital, Dundee- Scotland

    Dundee, United Kingdom · Recruiting

  • Royal London Hospital

    London, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.